A look at the results of the recently completed project, which aimed to develop an holistic monitoring system via process integration to more effectively control clinical trial risks beyond isolated RBM strategies.
Matthias Fehlinger, PhD
Advertisement
Articles by Matthias Fehlinger, PhD
Advertisement
Latest Updated Articles
The PUEKS Project: Process Innovation in Clinical Trial MonitoringPublished: August 22nd 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
